ArticleFrontiers in immunology2026

Oncolytic virus-mediated GPC3 delivery overcomes antigen heterogeneity in hepatocellular carcinoma and enhances GPC3-directed immunotherapy.

Shyambabu Chaurasiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.